Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

Myeloperoxidase-antineutrophil Cytoplasmic Antibodies with Cytoplasmic Fluorescence Pattern.

Chhabra S, Minz RW, Goyal L, Sharma N.

J Lab Physicians. 2010 Jan;2(1):42-3. doi: 10.4103/0974-2727.66707.

2.

Antineutrophil cytoplasmic antibodies in Wegener's granulomatosis.

Wong SN, Shah V, Dillon MJ.

Arch Dis Child. 1998 Sep;79(3):246-50.

3.

A review of immunofluorescent patterns associated with antineutrophil cytoplasmic antibodies (ANCA) and their differentiation from other antibodies.

Savige JA, Paspaliaris B, Silvestrini R, Davies D, Nikoloutsopoulos T, Sturgess A, Neil J, Pollock W, Dunster K, Hendle M.

J Clin Pathol. 1998 Aug;51(8):568-75.

4.

Antineutrophil cytoplasmic antibodies in Wegener's granulomatosis and other diseases: clinical issues.

Galperin C, Hoffman GS.

Cleve Clin J Med. 1994 Nov-Dec;61(6):416-27. Review.

PMID:
7828332
5.

Low seroprevalence and poor specificity of antineutrophil cytoplasmic antibodies in tuberculosis.

Teixeira L, Mahr A, Jaureguy F, Noël LH, Nunes H, Lefort A, Barry S, Deny P, Guillevin L.

Rheumatology (Oxford). 2005 Feb;44(2):247-50. Epub 2004 Nov 16.

PMID:
15546964
7.

[Detection of antineutrophil cytoplasmic antibodies for the values of Wegener's granulomatosis diagnosis and activity judgment].

Zhang X, Jiang M, Chui J, Wang H, Ma J.

Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 1997 Aug;19(4):284-7. Chinese.

PMID:
10453568
8.

Diagnostic value of classical and atypical antineutrophil cytoplasmic antibody (ANCA) immunofluorescence patterns.

Wong RC, Silvestrini RA, Savige JA, Fulcher DA, Benson EM.

J Clin Pathol. 1999 Feb;52(2):124-8.

10.

[Antineutrophil cytoplasmic autoantibodies in systemic vasculitis].

Hagemo JS, Aasarød K, Moen T.

Tidsskr Nor Laegeforen. 2002 May 10;122(12):1185-8. Norwegian.

11.

ANCA: serology in Wegener's granulomatosis.

Pradhan VD, Badakere SS, Ghosh K, Almeida A.

Indian J Med Sci. 2005 Jul;59(7):292-300.

PMID:
16062016
12.

Cytoplasmic-anti-neutrophil cytoplasmic antibodies targeting myeloperoxidase in Wegener's granulomatosis: a rare phenomenon.

Venkatesh BM, Joshi S, Adhikary R.

Indian J Pathol Microbiol. 2014 Jul-Sep;57(3):470-2. doi: 10.4103/0377-4929.138777.

13.
14.
15.

Anti-myeloperoxidase autoantibodies in patients with necrotizing glomerular and alveolar capillaritis.

Bosch X, Mirapeix E, Font J, Cervera R, Ingelmo M, Khamashta MA, Revert L, Hughes GR, Urbano-Márquez A.

Am J Kidney Dis. 1992 Sep;20(3):231-9.

PMID:
1325737
16.

Prediction of relapses in Wegener's granulomatosis by measurement of antineutrophil cytoplasmic antibody levels: a prospective study.

Boomsma MM, Stegeman CA, van der Leij MJ, Oost W, Hermans J, Kallenberg CG, Limburg PC, Tervaert JW.

Arthritis Rheum. 2000 Sep;43(9):2025-33.

17.
18.

ANCA are detectable in nearly all patients with active severe Wegener's granulomatosis.

Finkielman JD, Lee AS, Hummel AM, Viss MA, Jacob GL, Homburger HA, Peikert T, Hoffman GS, Merkel PA, Spiera R, St Clair EW, Davis JC Jr, McCune WJ, Tibbs AK, Ytterberg SR, Stone JH, Specks U; WGET Research Group..

Am J Med. 2007 Jul;120(7):643.e9-14.

PMID:
17602941
19.

[Review article: Antineutrophil cytoplasmic antibody in small vessel vasculitis].

Nakano H, Ozaki S.

Rinsho Byori. 2010 May;58(5):480-9. Review. Japanese.

PMID:
20560457
20.

What do antineutrophil cytoplasmic antibodies (ANCA) tell us?

Savige J, Pollock W, Trevisin M.

Best Pract Res Clin Rheumatol. 2005 Apr;19(2):263-76. Review.

PMID:
15857795

Supplemental Content

Support Center